Barnes S Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):559-79. Review.
Bathen TF, Engan T, Krane J, Axelson D Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res. 2000 Jul-Aug;20(4):2393-408.
Cassidy A, Bingham S, Setchell K Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr. 1995 Oct;74(4):587-601.
Cassidy A, Bingham S, Setchell KD Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994 Sep;60(3):333-40.
Clemons M, Goss P Estrogen and the risk of breast cancer. N Engl J Med. 2001 Jan 25;344(4):276-85. Review. Erratum in: N Engl J Med 2001 Jun 7;344(23):1804.
Doll R, Peto R The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191-308. Review.
Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):581-6.
El-Bayoumy K, Sinha R Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res. 2004 Jul 13;551(1-2):181-97. Review.
Fan S, Meng Q, Auborn K, Carter T, Rosen EM BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer. 2006 Feb 13;94(3):407-26.
Grover PL, Martin FL The initiation of breast and prostate cancer. Carcinogenesis. 2002 Jul;23(7):1095-102. Review.
Hu YJ, Diamond AM Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003 Jun 15;63(12):3347-51.
Ip C Lessons from basic research in selenium and cancer prevention. J Nutr. 1998 Nov;128(11):1845-54. Review.
Katdare M, Osborne M, Telang NT Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol. 2002 Oct;21(4):809-15.
Lü J, Jiang C Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1715-27. Review.
Messina MJ, Loprinzi CL Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.
Nutritional aspects of the development of cancer Report of the Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. Rep Health Soc Subj (Lond). 1998;48:i-xiv, 1-274. Review.
Paglia DE, Valentine WN Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967 Jul;70(1):158-69.
Shah YM, Al-Dhaheri M, Dong Y, Ip C, Jones FE, Rowan BG Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol Cancer Ther. 2005 Aug;4(8):1239-49.
Tsubura A, Uehara N, Kiyozuka Y, Shikata N Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia. 2005 Jan;10(1):87-100. Review.
Whanger PD Selenium and its relationship to cancer: an update. Br J Nutr. 2004 Jan;91(1):11-28. Review.
Xiang H, Schevzov G, Gunning P, Williams HM, Silink M A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Nutr Cancer. 2002;42(2):224-32.
Xu X, Duncan AM, Merz BE, Kurzer MS Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1101-8.
Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, Yang Q Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):59-65.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
